24 May 2013
Keywords: new, augmentin, generic, ranbaxy, pharmaceuticals, been, granted
Article | 31 March 2003
Ranbaxy Pharmaceuticals has been granted marketing approval in the USAfor a generic version of the the oral suspension formulation of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 March 2003
7 April 2003
© 2013 thepharmaletter.com